Trends and Disparities in Acute Myocardial Infarction‐Related Mortality With Co‐Listed Nicotine Dependence in the United States, 1999–2020
Open Access
- 23 June 2026
- journal article
- Published by Wiley in Clinical Cardiology
- Vol. 49 (6) , e70392
Abstract
Background: Nicotine use is a major modifiable risk factor for acute myocardial infarction (AMI), yet national mortality patterns involving co‐listed nicotine dependence remain under‐characterized. Methods: Using CDC WONDER Multiple Cause of Death data from 1999 to 2020, we evaluated AMI‐related mortality among US adults aged ≥ 25 years with co‐listed death‐certificate‐coded nicotine dependence, operationally defined using ICD‐10 F17.0–F17.9. AMI was identified using ICD‐10 I21.0–I22.9. Age‐adjusted mortality rates (AAMRs) per 100 000 population were calculated using the 2000 US standard population. Temporal trends were assessed using Joinpoint regression and stratified by sex, age, race/ethnicity, region, urbanization, state, and place of death. Results: From 1999 to 2020, 357 167 AMI‐related deaths with co‐listed nicotine dependence occurred among adults aged ≥ 25 years. The AAMR increased from 1.64 to 9.46 per 100 000 population (average annual percent change, 10.27%; p < 0.001). Men had higher AAMRs than women (11.30 vs. 4.27), with significant increases in both groups. Mortality increased with age, highest among adults aged ≥ 85 years (33.55) and lowest among those aged 35–44 years (0.83). Non‐Hispanic American Indian/Alaska Native adults had the highest AAMR (10.30). Rates were higher in the Midwest and South, nonmetropolitan areas exceeded metropolitan areas, and the highest state‐level AAMRs occurred in North Dakota and Wyoming. Most deaths occurred in inpatient facilities or at home. Conclusion: AMI‐related mortality with co‐listed nicotine dependence increased substantially from 1999 to 2020, with persistent demographic and geographic disparities. These findings may inform targeted tobacco‐control, nicotine‐cessation, and cardiovascular prevention strategies for high‐risk populations over time.Keywords
This publication has 14 references indexed in Scilit:
- Trends in Nicotine Product Use Among US Adolescents, 1999-2020JAMA Network Open, 2021
- Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019The Lancet, 2021
- Rural-Urban DisparitiesJACC, 2021
- Vaping and cardiac diseaseHeart, 2021
- National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysisEnvironmental Health and Preventive Medicine, 2021
- A Comparison of Gender Differences in Smoking Behaviors, Intention to Quit, and Nicotine Dependence among Thai University StudentsJournal of Addiction, 2018
- Smoking, nicotine dependence and nicotine intake by socio-economic status and marital statusAddictive Behaviors, 2014
- General mechanisms of nicotine‐induced fibrogenesisThe FASEB Journal, 2012
- Nicotine, CO and HCN: the detrimental effects of smoking on wound healingBritish Journal of Community Nursing, 2003
- Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco.JACC, 1997